Your session is about to expire
← Back to Search
Virus Therapy
Intramuscular vaccine for COVID-19
Phase 2 & 3
Waitlist Available
Research Sponsored by Medicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through efficacy analysis, approximately 4 months
Awards & highlights
Study Summary
Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults
Eligible Conditions
- COVID-19
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through efficacy analysis, approximately 4 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through efficacy analysis, approximately 4 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Phase 2 portion: Immediate adverse event (AEs)
Phase 2 portion: Number of subjects with normal and abnormal clinically significant biochemical values
Phase 2 portion: Number of subjects with normal and abnormal clinically significant haematological values
+9 moreSecondary outcome measures
Phase 2 portion: Laboratory-confirmed (virologic method) symptomatic SARS-CoV-2 infection
Phase 2 portion: Neutralizing antibody (Nab assay) response
Antibodies, Blocking
+27 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: 3.75 µg of CoVLP Vaccine adjuvantedExperimental Treatment1 Intervention
3.75 µg of CoVLP adjuvanted vaccine with AS03 adjuvant (0.5 mL)
Group II: PlaceboPlacebo Group1 Intervention
Placebo (0.5 mL)
Find a Location
Who is running the clinical trial?
MedicagoLead Sponsor
18 Previous Clinical Trials
28,442 Total Patients Enrolled
3 Trials studying COVID-19
308 Patients Enrolled for COVID-19
Brian Ward, MDStudy DirectorMedicago
4 Previous Clinical Trials
1,567 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger